Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder

NCT04470037 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT04470037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04470037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
Lead sponsor
China Medical University Hospital
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2016
Completion date
September 30, 2025
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease with dementia